Sienna Cancer Diagnostics IPO

Sienna Cancer Diagnostics have come up with a breakthrough method for detecting early stage bladder cancer

They are an established diagnostics company ready to expand globally

  1. Already on target to turn a profit
  2. Regulatory approval in the USA, EUR & AUS
  3. 100% rebatable in the USA

If you're interested in getting involved, download a prospectus and submit an application. Ensure you enter 'SEQ' as the Adviser/Broker code to get the best chance of receiving your allocation


Financial News Network (FNN) Interview with Sienna CEO Matthew Hoskin


Sienna Diagnostics IPO - Investor Presentation